Ginkgo Bioworks DNA Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | —— | —— | —— | ||
| $160.07M-29.5% | $227.04M-9.7% | $251.46M-47.4% | $477.71M+52.2% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $243.77M-42.5% | $424.06M-27.0% | $580.62M-44.8% | $1.05B-8.4% | ||
| $173.97M-29.3% | $246.16M-36.1% | $385.03M-73.1% | $1.43B+65.7% | ||
| —— | —— | —— | —— | ||
| -$307.28M+45.1% | -$559.76M+35.2% | -$864.41M+60.9% | -$2.21B-20.8% | ||
| -192%+54.6pp | -246.5%+97.2pp | -343.8%+119pp | -462.4%+120pp | ||
| —— | —— | -$28.53M-133% | $87.55M— | ||
| -$305.95M+44.1% | -$547.51M+38.7% | -$892.94M+57.9% | -$2.12B-15.4% | ||
| -$837K-74.7% | -$479K-575% | -$71K+99.5% | -$15.03M-915% | ||
| -$248.29M+50.0% | -$496.74M+37.4% | -$793.9M+63.4% | -$2.17B-20.4% | ||
| -155.1%+63.7pp | -218.8%+96.9pp | -315.7%+138pp | -453.5%+120pp | ||
| -$307.28M+45.1% | -$559.76M+35.2% | -$864.41M+60.9% | -$2.21B-20.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ginkgo Bioworks's revenue?
- Ginkgo Bioworks (DNA) generated $141.3M in revenue over the trailing twelve months, down 37.8% year over year.
- Is Ginkgo Bioworks profitable?
- Ginkgo Bioworks is not currently profitable: it reported a net loss of $304.4M over the trailing twelve months, a -215.4% net margin.
- Where does Ginkgo Bioworks's income statement data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
